Most Popular Brands: Pristiq
Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is an extended release formulation believed to treat depression by affecting the levels of serotonin and norepinephrine, two neurotransmitters associated with depression.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Depression | 70 |
|
|
|
|
|
21 |
| Treat my mood condition(s) | 28 |
|
|
|
|
9 | |
| Major Depressive Disorder | 14 |
|
|
3 | |||
| Bipolar Disorder | 11 |
|
|
2 | |||
| Anxiety | 10 |
|
|
|
4 | ||
| Other | 7 |
|
|
|
3 |
See all 128 patients currently taking Desvenlafaxine
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
16 | 42% |
|
|
Side effects too severe
|
15 | 39% |
|
|
Expense
|
6 | 16% |
|
|
Other
|
6 | 16% |
|
|
Doctor's advice
|
5 | 13% |
|
|
Personal research
|
2 | 5% |
|
Report created on November 21, 2009.